Lv31
370 积分 2024-11-21 加入
Analytical comparability to evaluate impact of manufacturing changes of ARX788, an Anti-HER2 ADC in late-stage clinical development
4小时前
待确认
An Improved Impact Ratio for Identifying Critical Process Parameters in Pharmaceutical Manufacturing Processes
2天前
已完结
Clearance of extractables and leachables from single‐use technologies via ultrafiltration/diafiltration operations
8天前
已完结
Clearance of extractables and leachables from single‐use technologies via ultrafiltration/diafiltration operations
8天前
已关闭
A Review of Conjugation Technologies for Antibody Drug Conjugates
1个月前
已完结
Development of Commercial-Ready Processes for Antibody Drug Conjugates
2个月前
已完结
Antibody Conjugates: From Heterogeneous Populations to Defined Reagents
2个月前
已完结
General strategies for IgG‐like bispecific antibody purification
2个月前
已完结
Fundamental properties and principal areas of focus in antibody-drug conjugates formulation development
2个月前
已完结
Kinetic Studies of the Partial Reduction and Conjugation Reactions in an Antibody-Drug Conjugate (ADC) Synthesis
2个月前
已完结
皖公网安备34019202002308
